Dimensional World Ex U.S. Core Equity 2 ETF (DFAX)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Generally, the Advisor buys and sells securities for the Portfolio with the goals of: (i) delaying and minimizing the realization of net capital gains (e.g., selling stocks with capital losses to offset gains, realized or anticipated); and (ii) maximizing the extent to which any realized net capital gains are long-term in nature (i.e., taxable at lower capital gains tax rates). The Portfolio is designed to purchase a broad and diverse group of equity securities of non-U.S. companies in countries...

Phone: 512-306-7400
StocktwitsNews
StocktwitsNews Aug. 7 at 1:09 PM
Toyota Warns Higher U.S. Tariff Impact For FY26: Retail Sees No Reason To Cheer $TM $DFAX $EHLS https://stocktwits.com/news/equity/markets/toyota-warns-higher-us-tariff-impact-for-fy26/chrmEbQRdd6
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 1:50 PM
Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-downgraded-by-ubs-over-uncertain-outlook-for-wegovy/chrLss6Rd2L
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 31 at 4:47 PM
Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside $STLA $DFAX $STXV https://stocktwits.com/news/equity/markets/stellantis-appoints-scott-kruger-to-head-north-american-design-amid-sales-slump/choLhAiRdG3
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 30 at 6:52 PM
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-hit-with-stock-downgrades-after-lowering-full-year-outlook/choXaUrR5CZ
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 30 at 1:10 PM
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’ $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/gsk-expects-full-year-earnings-at-top-end-of-guidance/choXcuPR5zz
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 29 at 2:33 PM
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-slashes-full-year-guidance/cho9UwAR5yE
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 15 at 5:50 PM
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/us-fda-reviewers-highlight-safety-concerns-with-gsk-investigational-cancer-drug/ch8QfPRR5FC
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 14 at 2:58 PM
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React $AZN $DFAX $QQMG https://stocktwits.com/news/equity/markets/astrazeneca-experimental-drug-lowers-blood-pressure-in-late-stage-study/ch8B63WR5Vw
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 14 at 1:05 PM
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/gsk-seeks-fda-approval-for-rsv-vaccine-in-more-adults/ch8ByXHR5Vp
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 11 at 6:36 PM
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-fails-to-block-heart-failure-drugs-generic-from-launching-through-2026-report/ch8cmAbR5Ne
0 · Reply
Latest News on DFAX
DFAX: A Bet On A Changing Global Economic Dynamic

Jun 15, 2024, 8:00 AM EDT - 1 year ago

DFAX: A Bet On A Changing Global Economic Dynamic

StocktwitsNews
StocktwitsNews Aug. 7 at 1:09 PM
Toyota Warns Higher U.S. Tariff Impact For FY26: Retail Sees No Reason To Cheer $TM $DFAX $EHLS https://stocktwits.com/news/equity/markets/toyota-warns-higher-us-tariff-impact-for-fy26/chrmEbQRdd6
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 1:50 PM
Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-downgraded-by-ubs-over-uncertain-outlook-for-wegovy/chrLss6Rd2L
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 31 at 4:47 PM
Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside $STLA $DFAX $STXV https://stocktwits.com/news/equity/markets/stellantis-appoints-scott-kruger-to-head-north-american-design-amid-sales-slump/choLhAiRdG3
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 30 at 6:52 PM
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-hit-with-stock-downgrades-after-lowering-full-year-outlook/choXaUrR5CZ
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 30 at 1:10 PM
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’ $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/gsk-expects-full-year-earnings-at-top-end-of-guidance/choXcuPR5zz
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 29 at 2:33 PM
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug $NVO $DFAX https://stocktwits.com/news/equity/markets/novo-nordisk-slashes-full-year-guidance/cho9UwAR5yE
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 15 at 5:50 PM
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/us-fda-reviewers-highlight-safety-concerns-with-gsk-investigational-cancer-drug/ch8QfPRR5FC
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 14 at 2:58 PM
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React $AZN $DFAX $QQMG https://stocktwits.com/news/equity/markets/astrazeneca-experimental-drug-lowers-blood-pressure-in-late-stage-study/ch8B63WR5Vw
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 14 at 1:05 PM
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance $GSK $DFAX $FDWM https://stocktwits.com/news/equity/markets/gsk-seeks-fda-approval-for-rsv-vaccine-in-more-adults/ch8ByXHR5Vp
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 11 at 6:36 PM
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-fails-to-block-heart-failure-drugs-generic-from-launching-through-2026-report/ch8cmAbR5Ne
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 8 at 4:00 PM
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe $NVO $DFAX $GGRW https://stocktwits.com/news/equity/markets/novo-nordisk-seeks-approval-for-higher-wegovy-dose-in-europe/chFvDEAR5Wj
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 8 at 11:44 AM
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-gets-swiss-authority-nod-for-first-malaria-drug-in-newborns-young-infants/chFvYaxR5gZ
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 7 at 6:35 PM
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers $STLA $DFAX $EFAS https://stocktwits.com/news/equity/markets/stellantis-production-in-italy-slumps-27-percent-in-h1-2025-says-union/chFttdbR5Qe
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 7 at 11:32 AM
US Regulator Initiates Recall Query Into Nearly 1.2M Stellantis Ram Trucks: Retail Sentiment Dips $STLA $DFAX $EFAS https://stocktwits.com/news/equity/markets/us-regulator-initiates-recall-query-into-nearly-1.2-million-stellantis-ram-trucks/chFt1HAR574
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 3 at 1:00 PM
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish $NVS $DFAX $APIE https://stocktwits.com/news/equity/markets/novartis-drug-fails-late-stage-trial-in-disease-causing-blood-vessel-inflammation/chFjsnERcNX
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 2 at 1:00 PM
Stellantis’ US Sales Drop Results In Downgrade At Wolfe, Firm Flags ‘Meaningful Risk’ To 2025, 2026 Earnings $STLA $DFAX $EFAS https://stocktwits.com/news/equity/markets/stellantis-us-sales-drop-results-in-downgrade-at-wolfe/chF0Z1MRTse
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 1 at 5:39 PM
Toyota’s US Sales Rise 7.2% In Q2 Despite A Dull June: Here’s What Drove Demand For The Japanese Carmaker $TM $DFAX $TMH https://stocktwits.com/news/equity/markets/toyota-us-sales-rise-7.2-percent-in-q2-despite-dull-june/chFWmACRRCM
0 · Reply
macroaxis
macroaxis Jun. 27 at 2:20 AM
$DFAX - Dimensional World Sees Decreasing Implied Volatility, Now at 0.44 https://www.macroaxis.com/stock-options/DFAX/Dimensional-World-ex?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
FBP
FBP Jun. 4 at 3:41 PM
$DFAX An ok international etf for exposure.
0 · Reply